Doug Wilson

Chief Tech/Sci/R&D Officer at

Ferghana Partners Group

89 year

27 connections

Health Technology

Finance

Consumer Non-Durables

Profile

Douglas John Wilson is currently the Director at Vaxxit SRL, Mainz Consulting Ltd., and the Chief Medical Officer at Ferghana Partners Group.
He previously served as Chairman at SeaDragon Ltd. from 2012 to 2015, Chairman at Adherium (NZ) Ltd., Non-Executive Chairman at Adherium Ltd., and Non-Independent Executive Director at Neuren Pharmaceuticals Ltd. from 2011 to 2012.
He also served as Non-Executive Director at PYC Therapeutics Ltd. from 2007 to 2016 and as Independent Non-Executive Director at Photonz Corp.
Ltd. from 2011 to 2013.
Additionally, he is currently serving as an Independent Non-Executive Director at AFT Pharmaceuticals Ltd. since 2012.
He previously worked as Senior Vice President-Medical & Regulatory Affairs at Boehringer Ingelheim Pharmaceuticals, Inc. He holds a doctorate degree from the University of London.

Doug Wilson active positions

Companies	Position	Start
Vaxxit SRL Vaxxit SRL BiotechnologyHealth Technology Develops a live recombinant vaccine for the treatment of oral herpes and genital herpes	Director/Board Member	-
Mainz Consulting Ltd.	Director/Board Member	-
Ferghana Partners Group Ferghana Partners Group Investment ManagersFinance Provides healthcare corporate finance advisory services	Chief Tech/Sci/R&D Officer	-

All active positions of Doug Wilson

Former positions of Doug Wilson

Companies	Position	End
AFT PHARMACEUTICALS LIMITED	Director/Board Member	2022-08-04
PYC THERAPEUTICS LIMITED	Chairman	2015-10-07
SEADRAGON LIMITED	Chairman	2015-05-03
ADHERIUM LIMITED	Chairman	2016-08-31
Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products	Chief Tech/Sci/R&D Officer	-

See the detail of Doug Wilson's experience

Training of Doug Wilson

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Doug Wilson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	12
Neuren Pharmaceuticals Ltd. Neuren Pharmaceuticals Ltd. Pharmaceuticals: GenericHealth Technology Manufactures drugs for neurological disorders	Health Technology
Ferghana Partners Group Ferghana Partners Group Investment ManagersFinance Provides healthcare corporate finance advisory services	Finance
SeaDragon Ltd. SeaDragon Ltd. Food: Specialty/CandyConsumer Non-Durables Engages in refining, blending and supplying omega fish oils	Consumer Non-Durables
University of London University of London Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
PYC Therapeutics Ltd. PYC Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides discovery and development of peptide based therapeutic candidates	Health Technology
Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products	Health Technology
Adherium (NZ) Ltd. Adherium (NZ) Ltd. Packaged SoftwareTechnology Services Develops digital health technologies that address sub-optimal medication use in chronic disease	Technology Services
Photonz Corp. Ltd. Photonz Corp. Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which produces the omega-3 fatty acid eicosapentaenoic acid	Health Technology
AFT Pharmaceuticals Ltd. AFT Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Adherium Ltd. Adherium Ltd. Medical SpecialtiesHealth Technology Develops and manufactures solutions for the pharmaceutical sector	Health Technology
Vaxxit SRL Vaxxit SRL BiotechnologyHealth Technology Develops a live recombinant vaccine for the treatment of oral herpes and genital herpes	Health Technology
Mainz Consulting Ltd.